{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:38:20Z","timestamp":1792787900098,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100006162","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Ci\u00eancia e Tecnologia do Estado de Pernambuco","doi-asserted-by":"publisher","award":["IBPG-1902-4.03\/22"],"award-info":[{"award-number":["IBPG-1902-4.03\/22"]}],"id":[{"id":"10.13039\/501100006162","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006162","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Ci\u00eancia e Tecnologia do Estado de Pernambuco","doi-asserted-by":"publisher","award":["APQ-0422-2.02\/19"],"award-info":[{"award-number":["APQ-0422-2.02\/19"]}],"id":[{"id":"10.13039\/501100006162","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Health Secretariat of Pernambuco","award":["10\/2021"],"award-info":[{"award-number":["10\/2021"]}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11663-2","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:10:58Z","timestamp":1759399858000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of complement system proteins on the clinical progression of hospitalized patients with COVID-19"],"prefix":"10.1186","volume":"25","author":[{"given":"Lorena Viana","family":"de Andrade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Vasconcelos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Khouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Dornels Freire","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anderson da Costa","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Feliciano","family":"do Carmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"key":"11663_CR1","unstructured":"COVID-19 Weekly Epidemiological Update [Internet]. 2023. Available from: https:\/\/iris.who.int\/bitstream\/handle\/10665\/366534\/nCoV-weekly-sitrep16Mar23-eng.pdf?sequence=1.\u200c"},{"key":"11663_CR2","doi-asserted-by":"publisher","unstructured":"Schiela B, Bernklau S, Malekshahi Z, Deutschmann D, Koske I, Banki Z, et al. Active human complement reduces the Zika virus Load via formation of the Membrane-Attack complex. Front Immunol. 2018;9. https:\/\/doi.org\/10.3389\/fimmu.2018.02177.","DOI":"10.3389\/fimmu.2018.02177"},{"key":"11663_CR3","doi-asserted-by":"publisher","unstructured":"Noris M, Remuzzi G. Overview of Complement Activation and Regulation. Seminars in Nephrology [Internet]. 2013;33(6):479\u201392. Available from: https:\/\/doi.org\/10.1016\/j.semnephrol.2013.08.001","DOI":"10.1016\/j.semnephrol.2013.08.001"},{"issue":"2","key":"11663_CR4","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1093\/infdis\/162.2.331","volume":"162","author":"SL Harris","year":"1990","unstructured":"Harris SL, Frank I, Vee A, Cohen GH, Eisenberg RJ, Friedman HM. Glycoprotein C of herpes simplex virus type 1 prevents Complement-Mediated cell Lysis and virus neutralization. J Infect Dis. 1990;162(2):331\u20137. https:\/\/doi.org\/10.1093\/infdis\/162.2.331.","journal-title":"J Infect Dis"},{"issue":"9","key":"11663_CR5","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1099\/vir.0.81199-0","volume":"86","author":"X Ji","year":"2005","unstructured":"Ji X. Mannose-binding lectin binds to Ebola and Marburg envelope glycoproteins, resulting in blocking of virus interaction with DC-SIGN and complement-mediated virus neutralization. J Gen Virol. 2005;86(9):2535\u201342. https:\/\/doi.org\/10.1099\/vir.0.81199-0.","journal-title":"J Gen Virol"},{"key":"11663_CR6","volume-title":"Primer to the immune response","author":"TW Mak","year":"2014","unstructured":"Mak TW, Jett EM. BD. Primer to the immune response. 2nd ed. Burlington, Ma, Usa: Ap Cell Press, An Imprint Of Elsevier; 2014.","edition":"2"},{"key":"11663_CR7","first-page":"327","volume-title":"Springer seminars in immunopathology","author":"NR Cooper","year":"1983","unstructured":"Cooper NR, Nemerow GR. December). Complement, viruses, and virus-infected cells. Springer seminars in immunopathology. Volume 6. New York: Springer-; 1983. pp. 327\u201347. 4."},{"key":"11663_CR8","doi-asserted-by":"publisher","unstructured":"Java A, Apicelli AJ, Liszewski MK, Coler-Reilly A, Atkinson JP, Kim AHJ et al. The complement system in COVID-19: friend and foe? JCI Insight [Internet]. 2020;5(15). Available from: https:\/\/doi.org\/10.1172\/jci.insight.140711","DOI":"10.1172\/jci.insight.140711"},{"key":"11663_CR9","doi-asserted-by":"publisher","first-page":"108598","DOI":"10.1016\/j.clim.2020.108598","volume":"220","author":"DC Mastellos","year":"2020","unstructured":"Mastellos DC, Pires da Silva BGP, Fonseca BAL, Fonseca NP, Auxiliadora-Martins M, Mastaglio S, et al. Complement C3 vs C5 Inhibition in severe COVID-19: early clinical findings reveal differential biological efficacy. Clin Immunol. 2020;220:108598. https:\/\/doi.org\/10.1016\/j.clim.2020.108598.","journal-title":"Clin Immunol"},{"key":"11663_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2020.04.007","author":"C Magro","year":"2020","unstructured":"Magro C, Mulvey JJ, Berlin D, Nuovo G, Salvatore S, Harp J, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Translational Res. 2020. https:\/\/doi.org\/10.1016\/j.trsl.2020.04.007.","journal-title":"Translational Res"},{"issue":"6","key":"11663_CR11","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.immuni.2021.05.010","volume":"54","author":"L Bergamaschi","year":"2021","unstructured":"Bergamaschi L, Mescia F, Turner L, Hanson AL, Kotagiri P, Dunmore BJ, et al. Longitudinal analysis reveals that delayed bystander CD8\u2009+\u2009T cell activation and early immune pathology distinguish severe COVID-19 from mild disease. Immunity. 2021;54(6):1257\u2013e12758. https:\/\/doi.org\/10.1016\/j.immuni.2021.05.010.","journal-title":"Immunity"},{"key":"11663_CR12","doi-asserted-by":"publisher","unstructured":"de Nooijer AH, Grondman I, Janssen NAF, Netea MG, Willems L, van de Veerdonk FL et al. Complement Activation in the Disease Course of Coronavirus Disease 2019 and Its Effects on Clinical Outcomes. The Journal of Infectious Diseases [Internet]. 2021 Feb 3 [cited 2022 Feb 10];223(2):214\u201324. Available from: https:\/\/doi.org\/10.1093\/infdis\/jiaa646","DOI":"10.1093\/infdis\/jiaa646"},{"key":"11663_CR13","doi-asserted-by":"publisher","unstructured":"Sinkovits G, Mez\u0151 B, R\u00e9ti M, M\u00fcller V, Iv\u00e1nyi Z, G\u00e1l J et al. Complement Overactivation and Consumption Predicts In-Hospital Mortality in SARS-CoV-2 Infection. Frontiers in Immunology [Internet]. 2021;12. Available from: https:\/\/doi.org\/10.3389\/fimmu.2021.663187","DOI":"10.3389\/fimmu.2021.663187"},{"key":"11663_CR14","doi-asserted-by":"publisher","unstructured":"Gao T, Zhu L, Liu H, Zhang X, Wang T, Fu Y, et al. Highly pathogenic coronavirus N protein aggravates inflammation by MASP-2-mediated lectin complement pathway overactivation. Signal Transduct Target Therapy. 2022;7(1). https:\/\/doi.org\/10.1038\/s41392-022-01133-5.","DOI":"10.1038\/s41392-022-01133-5"},{"key":"11663_CR15","doi-asserted-by":"publisher","unstructured":"Niederreiter J, Eck C, Ries T, Hartmann A, M\u00e4rkl B, B\u00fcttner-Herold M, et al. Complement activation via the lectin and alternative pathway in patients with severe COVID-19. Front Immunol. 2022;13. https:\/\/doi.org\/10.3389\/fimmu.2022.835156.","DOI":"10.3389\/fimmu.2022.835156"},{"key":"11663_CR16","doi-asserted-by":"publisher","unstructured":"G\u00f6tz MP, Skjoedt MO, Bayarri-Olmos R, Hansen CB, P\u00e9rez-Al\u00f3s L, Jarlhelt I, et al. Lectin pathway enzyme MASP-2 and downstream complement activation in COVID-19. J Innate Immun. 2022;1\u201314. https:\/\/doi.org\/10.1159\/000525508.","DOI":"10.1159\/000525508"},{"key":"11663_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(22)00297-1","author":"APJ Vlaar","year":"2022","unstructured":"Vlaar APJ, Witzenrath M, van Paassen P, Heunks LMA, Mourvillier B, de Bruin S, et al. Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial. Lancet Respiratory Med. 2022. https:\/\/doi.org\/10.1016\/S2213-2600(22)00297-1.","journal-title":"Lancet Respiratory Med"},{"issue":"9","key":"11663_CR18","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1080\/14712598.2023.2235269","volume":"23","author":"MW McCarthy","year":"2023","unstructured":"McCarthy MW. Optimizing the use of vilobelimab for the treatment of COVID-19. Expert Opin Biol Ther. 2023;23(9):877\u201381. https:\/\/doi.org\/10.1080\/14712598.2023.2235269.","journal-title":"Expert Opin Biol Ther"},{"key":"11663_CR19","doi-asserted-by":"publisher","unstructured":"van Amstel MA, Lim T, R\u00fcckinger S, Seymour CW, Burnett BP, et al. Heterogeneity of treatment effect of vilobelimab in COVID-19: a secondary analysis of a randomised controlled trial. Crit Care. 2024;28(1). https:\/\/doi.org\/10.1186\/s13054-024-05004-z.","DOI":"10.1186\/s13054-024-05004-z"},{"key":"11663_CR20","doi-asserted-by":"publisher","unstructured":"Ali YM, Ferrari M, Lynch NJ, Yaseen S, Dudler T, Gragerov S et al. Lectin Pathway Mediates Complement Activation by SARS-CoV-2 Proteins. Frontiers in Immunology [Internet]. 2021 Jul 5 [cited 2022 Jan 28];12:714511. Available from: https:\/\/doi.org\/10.3389\/fimmu.2021.714511","DOI":"10.3389\/fimmu.2021.714511"},{"key":"11663_CR21","doi-asserted-by":"publisher","unstructured":"Stravalaci M, Pagani I, Paraboschi EM, Pedotti M, Doni A, Scavello F et al. Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules. Nature Immunology [Internet]. 2022 Feb 1 [cited 2023 Apr 7];23(2):275\u201386. Available from: https:\/\/doi.org\/10.1038\/s41590-021-01114-w","DOI":"10.1038\/s41590-021-01114-w"},{"issue":"1","key":"11663_CR22","doi-asserted-by":"publisher","first-page":"e23670","DOI":"10.1016\/j.heliyon.2023.e23670","volume":"10","author":"L Viana","year":"2024","unstructured":"Viana L, Vanessa, Vasconcelos B, Vasconcelos S, Khouri R, Dornels C, et al. High production MBL2 polymorphisms protect against COVID-19 complications in critically ill patients: A retrospective cohort study. Heliyon. 2024;10(1):e23670\u20130. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e23670.","journal-title":"Heliyon"},{"key":"11663_CR23","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2021.279155","author":"J Yu","year":"2021","unstructured":"Yu J, Gerber GF, Chen H, Yuan X, Chaturvedi S, Braunstein EM, et al. Complement dysregulation is associated with severe COVID-19 illness. Haematologica. 2021. https:\/\/doi.org\/10.3324\/haematol.2021.279155.","journal-title":"Haematologica"},{"key":"11663_CR24","doi-asserted-by":"publisher","unstructured":"Yu J, Yuan X, Chen H, Chaturvedi S, Braunstein EM, Brodsky RA. Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition. Blood [Internet]. 2020;136(18):2080\u20139. Available from: https:\/\/doi.org\/10.1182\/blood.2020008248","DOI":"10.1182\/blood.2020008248"},{"key":"11663_CR25","doi-asserted-by":"publisher","first-page":"108716","DOI":"10.1016\/j.clim.2021.108716","volume":"226","author":"A Satyam","year":"2021","unstructured":"Satyam A, Tsokos MG, Brook OR, Hecht JL, Moulton VR, Tsokos GC. Activation of classical and alternative complement pathways in the pathogenesis of lung injury in COVID-19. Clin Immunol. 2021;226:108716. https:\/\/doi.org\/10.1016\/j.clim.2021.108716.","journal-title":"Clin Immunol"},{"key":"11663_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00665-1","author":"B Afzali","year":"2021","unstructured":"Afzali B, Noris M, Lambrecht BN, Kemper C. The state of complement in COVID-19. Nat Rev Immunol. 2021. https:\/\/doi.org\/10.1038\/s41577-021-00665-1.","journal-title":"Nat Rev Immunol"},{"key":"11663_CR27","doi-asserted-by":"crossref","unstructured":"Ma L, Sahu SK, Cano M, Kuppuswamy V, Bajwa J, McPhatter J et al. Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection. Science Immunology [Internet]. 2021;6(59):eabh2259. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8158979\/","DOI":"10.1126\/sciimmunol.abh2259"},{"key":"11663_CR28","doi-asserted-by":"crossref","unstructured":"Holter JC, Pischke SE, de Boer E, Lind A, Jenum S, Holten AR, et al. Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients. Proceedings of the National Academy of Sciences of the United States of America [Internet]. 2020 Oct 6;117(40):25018\u201325. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7547220\/.","DOI":"10.1073\/pnas.2010540117"},{"key":"11663_CR29","doi-asserted-by":"crossref","unstructured":"Yan B, Freiwald T, Chauss D, Wang L, West E, Mirabelli C, et al. SARS-CoV-2 drives JAK1\/2-dependent local complement hyperactivation. Science Immunology. 2021 Apr 7;6(58):eabg0833. https:\/\/doi.org\/10.1126\/sciimmunol.abg0833.","DOI":"10.1126\/sciimmunol.abg0833"},{"issue":"2","key":"11663_CR30","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.jaci.2021.11.004","volume":"149","author":"J Boussier","year":"2022","unstructured":"Boussier J, Yatim N, Marchal A, Hadjadj J, Charbit B, El Sissy C, et al. Severe COVID-19 is associated with hyperactivation of the alternative complement pathway. J Allergy Clin Immunol. 2022;149(2):550\u2013e5562. https:\/\/doi.org\/10.1016\/j.jaci.2021.11.004.","journal-title":"J Allergy Clin Immunol"},{"key":"11663_CR31","doi-asserted-by":"publisher","unstructured":"Alosaimi B, Mubarak A, Hamed ME, Almutairi AZ, Alrashed AA, AlJuryyan A et al. Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality. Frontiers in Immunology [Internet]. 2021 Jul 1 [cited 2021 Oct 23];12:668725. Available from: https:\/\/doi.org\/10.3389\/fimmu.2021.668725","DOI":"10.3389\/fimmu.2021.668725"},{"key":"11663_CR32","doi-asserted-by":"publisher","unstructured":"Yaiza Senent, Inog\u00e9s S, de Andr\u00e9s L, Matteo B-D, Campo A, Carmona-Torre F, et al. Persistence of high levels of serum complement C5a in severe COVID-19 cases after hospital discharge. Front Immunol. 2021;12. https:\/\/doi.org\/10.3389\/fimmu.2021.767376.","DOI":"10.3389\/fimmu.2021.767376"},{"key":"11663_CR33","doi-asserted-by":"publisher","unstructured":"Bagherimoghaddam A, Houshang Rafatpanah, Mansouritorghabeh H. Elevated levels of C3, C4, and CH50 of the complement system in ICU and non-ICU patients with COVID\u201019. Health Sci Rep. 2022;5(2). https:\/\/doi.org\/10.1002\/hsr2.519.","DOI":"10.1002\/hsr2.519"},{"issue":"3","key":"11663_CR34","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/imm.13585","volume":"168","author":"MK Siggins","year":"2022","unstructured":"Siggins MK, Davies K, Fellows R, Thwaites RS, Baillie JK, Semple MG, et al. Alternative pathway dysregulation in tissues drives sustained complement activation and predicts outcome across the disease course in COVID-19. Immunology. 2022;168(3):473\u201392. https:\/\/doi.org\/10.1111\/imm.13585.","journal-title":"Immunology"},{"key":"11663_CR35","doi-asserted-by":"publisher","unstructured":"Bruni F, Panteleimon Charitos, Lampart M, Moser S, Siegemund M, Bingisser R, et al. Complement and endothelial cell activation in COVID-19 patients compared to controls with suspected SARS-CoV-2 infection: A prospective cohort study. Front Immunol. 2022;13. https:\/\/doi.org\/10.3389\/fimmu.2022.941742.","DOI":"10.3389\/fimmu.2022.941742"},{"key":"11663_CR36","doi-asserted-by":"publisher","unstructured":"Castanha P, Tuttle DJ, Kitsios GD, Jacobs JL, Ulisses Braga-Neto, Duespohl M et al. Contribution of Coronavirus-Specific Immunoglobulin G Responses to Complement Overactivation in Patients with Severe Coronavirus Disease 2019. The Journal of Infectious Diseases [Internet]. 2022;226(5):766\u201377. Available from: https:\/\/doi.org\/10.1093\/infdis\/jiac091","DOI":"10.1093\/infdis\/jiac091"},{"key":"11663_CR37","doi-asserted-by":"publisher","unstructured":"Henry BM, Gy\u00f6rgy Sinkovits, Szergyuk I, Helena M, Lippi G, Benoit JL, et al. Complement levels at admission reflecting progression to severe acute kidney injury (AKI) in coronavirus disease 2019 (COVID-19): A multicenter prospective cohort study. Front Med. 2022;9. https:\/\/doi.org\/10.3389\/fmed.2022.796109.","DOI":"10.3389\/fmed.2022.796109"},{"key":"11663_CR38","doi-asserted-by":"publisher","first-page":"849","DOI":"10.2147\/IJGM.S348519","volume":"15","author":"H Jiang","year":"2022","unstructured":"Jiang H, Chen Q, Zheng S, Guo C, Luo J, Wang H, et al. Association of complement C3 with clinical deterioration among hospitalized patients with COVID-19. Int J Gen Med. 2022;15:849\u201357. https:\/\/doi.org\/10.2147\/IJGM.S348519.","journal-title":"Int J Gen Med"},{"key":"11663_CR39","doi-asserted-by":"publisher","unstructured":"Kowalska D, Alicja Ku\u017aniewska Y, Senent, Tavira B, de Inog\u00e9s S. C5a elevation in convalescents from severe COVID-19 is not associated with early complement activation markers C3bBbP or C4d. Front Immunol. 2022;13. https:\/\/doi.org\/10.3389\/fimmu.2022.946522.","DOI":"10.3389\/fimmu.2022.946522"},{"key":"11663_CR40","doi-asserted-by":"publisher","unstructured":"Lage SL, Rocco JM, Laidlaw E, Rupert A, Galindo F, Kellogg A, et al. Activation of complement components on Circulating blood monocytes from COVID-19 patients. Front Immunol. 2022;13. https:\/\/doi.org\/10.3389\/fimmu.2022.815833.","DOI":"10.3389\/fimmu.2022.815833"},{"key":"11663_CR41","doi-asserted-by":"publisher","unstructured":"Devalaraja-Narashimha K, Ehmann PJ, Huang C, Ruan Q, Wipperman MF, Kaplan T et al. Association of complement pathways with COVID-19 severity and outcomes. Microbes and Infection [Internet]. 2023 May [cited 2024 Feb 17];25(4):105081. Available from: https:\/\/doi.org\/10.1016\/j.micinf.2022.105081","DOI":"10.1016\/j.micinf.2022.105081"},{"issue":"9","key":"11663_CR42","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.3390\/life12091335","volume":"12","author":"MG Detsika","year":"2022","unstructured":"Detsika MG, Diamanti E, Ampelakiotou K, Jahaj E, Tsipilis S, Athanasiou N, et al. C3a and C5b-9 differentially predict COVID-19 progression and outcome. Life (Basel). 2022;12(9):1335. https:\/\/doi.org\/10.3390\/life12091335.","journal-title":"Life (Basel)"},{"key":"11663_CR43","doi-asserted-by":"publisher","unstructured":"Carvelli J, Demaria O, V\u00e9ly F, Batista L, Chouaki Benmansour N, Fares J et al. Association of COVID-19 inflammation with activation of the C5a\u2013C5aR1 axis. Nature [Internet]. 2020;588(7836):146\u201350. Available from: https:\/\/doi.org\/10.1038\/s41586-020-2600-6","DOI":"10.1038\/s41586-020-2600-6"},{"issue":"8","key":"11663_CR44","doi-asserted-by":"publisher","first-page":"e1413","DOI":"10.1002\/cti2.1413","volume":"11","author":"MW Lo","year":"2022","unstructured":"Lo MW, Amarilla AA, Lee JD, Albornoz EA, Modhiran N, Clark RJ, et al. SARS-CoV-2 triggers complement activation through interactions with Heparan sulfate. Clin Transl Immunol. 2022;11(8):e1413. https:\/\/doi.org\/10.1002\/cti2.1413.","journal-title":"Clin Transl Immunol"},{"issue":"5","key":"11663_CR45","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.3390\/biomedicines11051371","volume":"11","author":"EP Ghanbari","year":"2023","unstructured":"Ghanbari EP, Jakobs K, Puccini M, Reinshagen L, Friebel J, Arash Haghikia, et al. The role of NETosis and complement activation in COVID-19-Associated coagulopathies. Biomedicines. 2023;11(5):1371\u20131. https:\/\/doi.org\/10.3390\/biomedicines11051371.","journal-title":"Biomedicines"},{"issue":"4","key":"11663_CR46","doi-asserted-by":"publisher","first-page":"53","DOI":"10.5493\/wjem.v12.i4.53","volume":"12","author":"P Gianni","year":"2022","unstructured":"Gianni P, Goldin M, Ngu S, Zafeiropoulos S, Geropoulos G, Giannis D. Complement-mediated microvascular injury and thrombosis in the pathogenesis of severe COVID-19: a review. World J Exp Med. 2022;12(4):53\u201367. https:\/\/doi.org\/10.5493\/wjem.v12.i4.53.","journal-title":"World J Exp Med"},{"key":"11663_CR47","doi-asserted-by":"publisher","unstructured":"Pfister F, Vonbrunn E, Ries T, J\u00e4ck HM, \u00dcberla K, Lochnit G, et al. Complement activation in kidneys of patients with COVID-19. Front Immunol. 2021;11. https:\/\/doi.org\/10.3389\/fimmu.2020.594849.","DOI":"10.3389\/fimmu.2020.594849"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11663-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11663-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11663-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:11:00Z","timestamp":1759399860000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11663-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11663"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11663-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]},"assertion":[{"value":"2 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Hospital das Cl\u00ednicas of the Federal University of Pernambuco (HC\/UFPE) under register number CAAE: 36613520.0.0000.5640. A free and informed consent form was obtained in accordance with the requirements of the Brazilian National Research Ethics Commission (CONEP, acronym in Portuguese).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Rodrigo Feliciano do Carmo is Senior Editor at BMC Infectious Diseases.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1231"}}